HCA Healthcare Inc
NYSE:HCA

Watchlist Manager
HCA Healthcare Inc Logo
HCA Healthcare Inc
NYSE:HCA
Watchlist
Price: 467.89 USD -1.13%
Market Cap: 106.8B USD

Intrinsic Value

The intrinsic value of one HCA stock under the Base Case scenario is 579.86 USD. Compared to the current market price of 467.89 USD, HCA Healthcare Inc is Undervalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HCA Intrinsic Value
579.86 USD
Undervaluation 19%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
HCA Healthcare Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about HCA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is HCA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for HCA Healthcare Inc.

Explain Valuation
Compare HCA to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

HCA’s reliance on government reimbursement programs (Medicare and Medicaid) exposes it to impending federal funding constraints, potentially reducing profitability if reimbursement cuts outpace cost-saving measures.

Escalating labor costs, driven by nursing shortages and inflationary pressures tied to competitive wage requirements, could erode margins and limit the company’s ability to expand or invest in growth initiatives.

The company’s accelerated capital spending to modernize facilities, coupled with elevated debt levels, eliminates financial flexibility and heightens vulnerability to adverse shifts in credit markets or economic conditions.

Bull Theses

HCA’s extensive hospital network and strong geographic footprint position it to capitalize on patient volume growth, creating leverage with insurers and driving margin expansion across its regions.

Management’s focus on operational efficiencies, including centralized purchasing and shared clinical protocols, has historically supported superior cost control, enabling robust cash flow generation and reinvestment.

A sustained shift toward outpatient services and newer service lines, such as urgent care facilities, allows HCA to diversify revenue streams, cater to changing patient preferences, and capture additional market share.

Show More Less
How do you feel about HCA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
HCA Healthcare Inc

Current Assets 15.3B
Cash & Short-Term Investments 997m
Receivables 10.4B
Other Current Assets 3.9B
Non-Current Assets 44.5B
Long-Term Investments 1.2B
PP&E 32.7B
Intangibles 10.3B
Other Non-Current Assets 277m
Current Liabilities 17.9B
Accounts Payable 4.6B
Accrued Liabilities 7.2B
Other Current Liabilities 6.1B
Non-Current Liabilities 47.2B
Long-Term Debt 38.4B
Other Non-Current Liabilities 8.8B
Efficiency

Free Cash Flow Analysis
HCA Healthcare Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
HCA Healthcare Inc

Revenue
74.4B USD
Cost of Revenue
-11.2B USD
Gross Profit
63.2B USD
Operating Expenses
-51.6B USD
Operating Income
11.6B USD
Other Expenses
-5.3B USD
Net Income
6.3B USD
Fundamental Scores

HCA Profitability Score
Profitability Due Diligence

HCA Healthcare Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
Positive 3Y Average ROIC
49/100
Profitability
Score

HCA Healthcare Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

HCA Solvency Score
Solvency Due Diligence

HCA Healthcare Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Low D/E
Average Altman Z-Score
Long-Term Solvency
Short-Term Solvency
43/100
Solvency
Score

HCA Healthcare Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HCA Price Targets Summary
HCA Healthcare Inc

Wall Street analysts forecast HCA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HCA is 490.21 USD with a low forecast of 376.94 USD and a high forecast of 551.25 USD.

Lowest
Price Target
376.94 USD
19% Downside
Average
Price Target
490.21 USD
5% Upside
Highest
Price Target
551.25 USD
18% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for HCA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

HCA Insider Trading
Buy and sell transactions by insiders

HCA News

Other Videos
What is the Intrinsic Value of one HCA stock?

The intrinsic value of one HCA stock under the Base Case scenario is 579.86 USD.

Is HCA stock undervalued or overvalued?

Compared to the current market price of 467.89 USD, HCA Healthcare Inc is Undervalued by 19%.

Back to Top